ArticleFrontiers in oncology2022

Assessment of Molecular Residual Disease Using Circulating Tumor DNA to Identify Multiple Myeloma Patients at High Risk of Relapse.

Binod Dhakal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.